BioLineRx (BLRX) Shares Outstanding (2021 - 2023)

BioLineRx has reported Shares Outstanding over the past 3 years, most recently at $1.1 billion for Q4 2023.

  • Quarterly results put Shares Outstanding at $1.1 billion for Q4 2023, up 17.73% from a year ago — trailing twelve months through Dec 2023 was $1.1 billion (up 17.73% YoY), and the annual figure for FY2023 was $1.1 billion, up 17.73%.
  • Shares Outstanding for Q4 2023 was $1.1 billion at BioLineRx, up from $923.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding for BLRX hit a ceiling of $1.1 billion in Q4 2023 and a floor of $715.2 million in Q4 2021.
  • Median Shares Outstanding over the past 3 years was $923.0 million (2022), compared with a mean of $908.2 million.
  • Biggest five-year swings in Shares Outstanding: rose 29.06% in 2022 and later increased 17.73% in 2023.
  • BioLineRx's Shares Outstanding stood at $715.2 million in 2021, then rose by 29.06% to $923.0 million in 2022, then rose by 17.73% to $1.1 billion in 2023.
  • The last three reported values for Shares Outstanding were $1.1 billion (Q4 2023), $923.0 million (Q4 2022), and $715.2 million (Q4 2021) per Business Quant data.